AVITA Medical (RCEL) Net Cash Flow (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Net Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | AVITA Medical | 309.50 Mn | 298.36 Mn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -261.54% |
| Sep 30, 2025 | 220.80% |
| Jun 30, 2025 | -423.66% |
| Mar 31, 2025 | 117.87% |
| Dec 31, 2024 | -486.60% |
| Sep 30, 2024 | 136.93% |
| Jun 30, 2024 | 109.70% |
| Mar 31, 2024 | 82.02% |
| Dec 31, 2023 | -314.65% |
| Sep 30, 2023 | 41.92% |
| Jun 30, 2023 | -4.57% |
| Mar 31, 2023 | 1,728.50% |
| Jun 30, 2022 | -100.24% |
| Sep 30, 2021 | 102.89% |
| Jun 30, 2021 | -147.02% |
| Mar 31, 2021 | 1,015.85% |
| Dec 31, 2020 | 24.88% |
| Mar 31, 2020 | -110.58% |
| Dec 31, 2019 | 1,527.92% |